• / Free eNewsletters & Magazine
  • / My Account
Home>What Maslow and Rand Would Tell Investors Today

What Maslow and Rand Would Tell Investors Today

Morningstar Articles

Tue, 2 Apr 2013

We're placing Barr Pharmaceuticals BRL under review while we evaluate the company's decision, announced Tuesday, to acquire Pliva. Barr is paying $2.2 billion in cash for the Croatia-based generic drug firm. The transaction geographically diversifies

Related Videos

  1. Winners and Losers in the Drug-Pricing War

    Major pharmacy benefit managers and pharma stocks with innovative pipelines should see the most upside, while companies that rely heavily on price increases for growth will likely suffer, says Morningstar's Matt Coffina.

  2. Practical Strategies for Today's Bond Market

    The outlook for bonds is just as cloudy as ever, but Morningstar's Miriam Sjoblom and Marta Norton offer helpful tips for setting the right expectations and creating a game plan in today's challenging bond market.

©2017 Morningstar Advisor. All right reserved.